Amgen 'failed to enable all that it has claimed, even allowing for a reasonable degree of experimentation.'
The specification must enable the full scope of the invention as defined by its claims.
Are patent applicants limited to claiming species? What steps may be taken to obtain broader coverage?
The Supreme Court clearly disapproved of broad genus claims.
[
add
]
[
|
|
...
]